Sabra Health Care REIT, Inc.
SBRA
$18.14
-$0.03-0.17%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.26% | 1.58% | 5.11% | -4.27% | -9.95% |
| Total Other Revenue | 24.83% | 23.22% | 16.43% | 15.10% | 462.93% |
| Total Revenue | 12.49% | 10.70% | 9.79% | 3.53% | 93.29% |
| Cost of Revenue | 20.58% | 18.72% | 11.04% | 13.15% | 12.68% |
| Gross Profit | 8.95% | 7.18% | 9.23% | -0.53% | 181.43% |
| SG&A Expenses | -21.87% | 15.29% | 33.67% | 13.22% | 53.68% |
| Depreciation & Amortization | -1.32% | -1.21% | -5.58% | -18.77% | -14.12% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.48% | 10.01% | 6.01% | -2.04% | 4.15% |
| Operating Income | 26.77% | 11.95% | 16.53% | 16.00% | 360.17% |
| Income Before Tax | 166.73% | 301.58% | 13.47% | 404.91% | 120.81% |
| Income Tax Expenses | -22.92% | -158.24% | 34.05% | -37.77% | 297.58% |
| Earnings from Continuing Operations | 172.18% | 297.26% | 13.15% | 376.74% | 120.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 172.18% | 297.26% | 13.15% | 376.74% | 120.20% |
| EBIT | 26.77% | 11.95% | 16.53% | 16.00% | 360.17% |
| EBITDA | 16.25% | 6.32% | 6.94% | -1.93% | 298.91% |
| EPS Basic | 166.04% | 294.64% | 12.99% | 376.59% | 120.17% |
| Normalized Basic EPS | 53.68% | 25.63% | 29.26% | 37.68% | 151.64% |
| EPS Diluted | 182.81% | 281.57% | 11.11% | 368.29% | 118.86% |
| Normalized Diluted EPS | 52.98% | 24.17% | 28.48% | 36.44% | 151.19% |
| Average Basic Shares Outstanding | 2.32% | 1.33% | 0.18% | 0.12% | 0.10% |
| Average Diluted Shares Outstanding | 2.76% | 2.52% | 0.65% | 0.95% | 0.96% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.62% | 1.51% | -0.12% | 1.36% | 5.96% |